Literature DB >> 1387555

Multiple venous thromboses and membranous obstruction of inferior vena cava in association with hereditary protein C deficiency: a case report.

R K Dhiman1, V A Saraswat, S Radhakrishnan, A Parashar, D K Agarwal, S R Naik.   

Abstract

A forty year old male presented with multiple dilated venous channels over the whole body involving both inferior and superior vena caval territories, along with features of chronic liver disease and portal hypertension. On investigation, he was found to have membranous obstruction of the inferior vena cava (MOIVC) as well as obstruction of both brachiocephalic and right subclavian veins and 'hereditary protein C deficiency'. He was managed successfully by percutaneous transluminal balloon angioplasty for the inferior vena cava (IVC) obstruction and was doing well on follow-up.

Entities:  

Mesh:

Year:  1992        PMID: 1387555     DOI: 10.1111/j.1440-1746.1992.tb01014.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  4 in total

1.  Dysgenesis of the inferior vena cava associated with deep venous thrombosis and a partial Protein C deficiency.

Authors:  Howard Tribe; Rudi Borgstein
Journal:  J Radiol Case Rep       Date:  2013-11-01

2.  Hepatocellular carcinoma in Budd-Chiari syndrome: a single center experience with long-term follow-up in South Korea.

Authors:  Hana Park; Jin Young Yoon; Kyeong Hye Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Chae Yoon Chon; Jun Yong Park
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

3.  Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment.

Authors:  Deepak N Amarapurkar; Sundeep J Punamiya; Nikhil D Patel
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

4.  The Development of Marked Collateral Circulation due to Inferior Vena Cava Filter Occlusion in a Patient with Chronic Thromboembolic Pulmonary Hypertension Complicated with Anti-phospholipid Syndrome.

Authors:  Hajime Kasai; Nobuhiro Tanabe; Ken Koshikawa; Yasutaka Hirasawa; Toshihiko Sugiura; Seiichiro Sakao; Koichiro Tatsumi
Journal:  Intern Med       Date:  2017-04-15       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.